Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

1-Benzyl-4-Cyano-4-Phenylpiperidine Hydrochloride

    • Product Name 1-Benzyl-4-Cyano-4-Phenylpiperidine Hydrochloride
    • Alias BTCP
    • Einecs 643-500-5
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    615880

    Chemicalname 1-Benzyl-4-Cyano-4-Phenylpiperidine Hydrochloride
    Molecularformula C19H20N2·HCl
    Molecularweight 312.84 g/mol
    Casnumber 99858-19-8
    Appearance white to off-white crystalline powder
    Solubility soluble in water and alcohols
    Meltingpoint 147-150°C (decomposes)
    Purity ≥98% (typical)
    Storageconditions Store at 2-8°C, protected from light and moisture

    As an accredited 1-Benzyl-4-Cyano-4-Phenylpiperidine Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Packaged in a sealed amber glass bottle, labeled clearly, containing 25 grams of 1-Benzyl-4-Cyano-4-Phenylpiperidine Hydrochloride.
    Shipping **Shipping Description:** 1-Benzyl-4-Cyano-4-Phenylpiperidine Hydrochloride is shipped in tightly sealed containers, clearly labeled and compliant with chemical transport regulations. It is packaged with appropriate cushioning material to prevent breakage and stored at controlled room temperature. Shipping includes necessary documentation, hazard information, and Material Safety Data Sheets (MSDS) for safe handling and transport.
    Storage 1-Benzyl-4-Cyano-4-Phenylpiperidine Hydrochloride should be stored in a tightly sealed container, protected from light, moisture, and incompatible materials. Store at room temperature, preferably between 15–25°C (59–77°F), in a well-ventilated, dry area. Ensure the storage location is secure and accessible only to authorized personnel. Follow all relevant safety and chemical hygiene procedures when handling and storing this compound.
    Application of 1-Benzyl-4-Cyano-4-Phenylpiperidine Hydrochloride

    Applications of 1-Benzyl-4-Cyano-4-Phenylpiperidine Hydrochloride in Industrial Manufacturing

    As a manufacturer specializing in upstream intermediates for the pharmaceutical and fine chemical industries, we supply 1-Benzyl-4-Cyano-4-Phenylpiperidine Hydrochloride for integration into highly specialized downstream processes. Its unique structural features support both API intermediate synthesis and advanced custom chemical R&D. Below, we detail established and compliant industrial application areas, each with specific technical parameters relevant for buyers focused on process reliability and regulatory adherence.

    1. Pharmaceutical Active Pharmaceutical Ingredient (API) Intermediate Synthesis

    Multiple major pharmaceutical producers use this material as a precision mid-stage intermediate in the multistep synthesis of target APIs, particularly in the field of central nervous system compound development. Its cyano and piperidine moieties support scaffold construction in clinical trial supply manufacturing, subject to full documentation and in-line process control for traceability.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • EU GMP Part II (APIs)
    • US FDA 21 CFR Part 211 (Process validation and auditability)

    Typical usage ratio

    • Used at stoichiometric levels in stepwise synthesis; ratio typically ranges from 0.8 to 1.1 equivalents relative to the preceding step’s limiting reagent, depending on reactant purity and process yield optimization.

    Downstream process integration

    • Charged during the central condensation or reductive amination step in multi-stage batch reactors under inert gas blanketing; entry point and reaction conditions are detailed in proprietary API route documentation.

    Final product types

    • Pharmaceutical active ingredients for CNS therapy candidates
    • Drug substance intermediates for New Chemical Entity (NCE) development
    • Reference standards for impurity profiling

    2. Fine Chemical Custom Synthesis for Contract Research and Manufacturing (CRMO/CDMO)

    Specialty fine chemical firms and CDMOs select this compound as a structured building block in the tailored assembly of advanced intermediates for early-phase medicinal chemistry campaigns. Its defined hydrochloride form allows controlled incorporation into route scouting operations, supporting synthesis of bespoke molecules for discovery chemistry.

    Industry compliance standards

    • ISO 9001:2015 Quality Management for Custom Synthesis
    • OECD Good Laboratory Practice (GLP) for Analytical Verification
    • Client specification and in-process control agreements

    Typical usage ratio

    • Dosed in a 1.0–1.2 molar ratio as a core skeleton, adjustable based on alternate reactants’ functional group excess; molar adjustments based on exploratory yield screens by client R&D teams.

    Downstream process integration

    • Introduced during manual or automated solution-phase assembly or fragment coupling processes; incorporated in early to mid-stage combinatorial reaction blocks prior to downstream functional group elaboration.

    Final product types

    • Milligram to multi-gram scale custom intermediates for pharma clients
    • Lead compound analogs for Structure-Activity Relationship (SAR) studies
    • Patentable new molecules for licensing or further scale-up

    3. CNS Drug Discovery Chemical Libraries

    Discovery platforms and biotech start-ups incorporate this building block in the modular synthesis of piperidine-based compound libraries. Its combined benzyl and cyano functionalities present a scaffold favored by research teams optimizing CNS penetration and metabolic stability in medicinal chemistry workflows, facilitating high-throughput screening sample generation.

    Industry compliance standards

    • ISO 17025 Laboratory Competence for Analytical Techniques
    • Company-specific library synthesis SOPs and purity verification protocols
    • GLP traceability for research project documentation

    Typical usage ratio

    • In library assembly, applied as 0.9–1.3 equivalents per coupling, with precise ratio determined by combinatorial design strategy, maximizing molecule diversity and minimizing unreacted precursor carryover.

    Downstream process integration

    • Processed in solution-phase library generation, automated microreactor loading, or parallel synthesis arrays, directly after core activation steps to streamline downstream deprotection and derivatization processes.

    Final product types

    • High-throughput library plates for CNS drug screening
    • Assay-ready compounds for in vitro and in vivo pharmacology studies
    • Internal hit-to-lead and preclinical screening materials

    4. Reference Standards and Analytical Controls

    Analytical laboratories and QC departments use high-purity lots of this hydrochloride for calibration, method validation, and as a positive control in impurity fingerprinting assays associated with both regulatory submissions and GMP batch release protocols. Its molecular stability and documented provenance support long-term integrity in regulated test environments.

    Industry compliance standards

    • USP and Ph. Eur. guidelines for reference materials
    • ISO 17034 Reference Material Producer Accreditation
    • ICH Q6A Specifications: Test Procedures and Acceptance Criteria

    Typical usage ratio

    • Utilized at calibration concentrations ranging from 0.05 mg/mL to 1 mg/mL in HPLC, GC-MS, or NMR analytic runs, adjusted by analytical method sensitivity and detection limit requirements.

    Downstream process integration

    • Prepared into certified reference solutions and analytical kits during QC chemical standard preparation; introduced as batch controls or spiked assay internal standards for periodic method validation.

    Final product types

    • Analytical reference standards
    • Quality control kits for pharmaceutical manufacturing
    • Batch release certificates and impurity marker standards

    5. Preclinical Bulk Intermediate Supply

    Integrated pharma operations and preclinical API manufacturers procure technical grade bulk quantities of this compound as an advanced feedstock supporting pilot-scale and tox lot campaigns. Process engineers tune feed-in specification to balance downstream conversion efficiency with regulatory safety documentation for Investigational New Drug (IND) studies.

    Industry compliance standards

    • ICH M7(R2) on Genotoxic Impurities for Early Development
    • ICH Q11 Development and Manufacture of Drug Substances
    • Controlled substance handling policies (as per local jurisdiction, if required)

    Typical usage ratio

    • Formulated at a batch scale between 0.7 and 1.0 equivalent to principal coupling agent, volume depending on projected step yield, process scale, and safety assessment of intermediate impurity carryover.

    Downstream process integration

    • Fed to preclinical reactors in single or multistep sequences ahead of purification and in-line crystallization; material handling and transfer documented for full IND-supporting traceability.

    Final product types

    • Preclinical drug substance for toxicological studies
    • Pilot plant process intermediates
    • Staged materials for scale-up and formulation feasibility batches
    Free Quote

    Competitive 1-Benzyl-4-Cyano-4-Phenylpiperidine Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    1-Benzyl-4-Cyano-4-Phenylpiperidine Hydrochloride: Direct from the Manufacturer’s Production Floor

    What 1-Benzyl-4-Cyano-4-Phenylpiperidine Hydrochloride Brings to the Table

    Over the last decade, chemists working at the bench and process engineers investing long hours on the production floor have seen demand for 1-Benzyl-4-Cyano-4-Phenylpiperidine Hydrochloride climb steadily. The reasons run deeper than simple market fluctuations. On the factory floor and in dialog with our long-term customers, we’ve found that this compound answers a recurring set of needs in pharmaceutical synthesis, particularly for those involved in complex structural assembly work. Our production team works closely with raw material suppliers for every batch, ensuring the input lots never drift from verified sources — an approach that matters when traceability impacts not just yield, but confidence in downstream results.

    Our current product,, often recognized by its structure featuring a cyano and phenyl substitution on the core piperidine scaffold, arrives as an off-white powder. We monitor crystal habit and bulk density right off the drying filter, with each drum and polybag mapped to batch records going back years. The hydrochloride salt form allows for stable transport over extended routes, resisting moisture absorption — a property that cuts waste both in our plant and in your warehouse. Technicians performing transfer steps between reactors or handling formulation staging prefer this format over the base, especially under variable humidity environments where free bases often fail to keep.

    Our Manufacturing Perspective on Model and Consistency

    From the very first vessels loaded for a new campaign, the challenge lies in controlling side reactions. Aromatic substitution on both ends of this piperidine means greater sensitivity to impurities from upstream alkylation steps and potential by-product formation during cyanation. We have invested in chromatography and in-line monitoring, not just spot checks, because active monitoring of every kilo moving through the process has taught us shortcuts always come back to haunt production managers’ sleep. Two seasoned synthesis leads on our team liken our present model to a closed-cycle approach: what goes into the reactor gets mapped out, and every output route gets tracked.

    Our in-house analytical group runs NMR, HPLC, and elemental analysis before any lot leaves the finish room. Differences in moisture content, leftover organic solvents, or salt balance stand out quickly with this compound. Exacting customers often ask about residual benzyl and phenyl precursors—we make sure limits line up with thresholds that customers’ own validation teams expect. Testing is not a sign-off ritual; for us, it prevents unpleasant surprises in scale-up batches outside the pilot plant.

    Applications and Real-World Contexts

    For those synthesizing CNS-active drug intermediates or working with research compounds where the piperidine core plays an essential role, reliable feedstock with known impurity fingerprints drives program timelines. No chemist wants ambiguous NMR peaks or delayed progression toward the next synthetic step. In earlier years, substitution on the piperidine ring posed a headache for those forced to start with variable raw material streams. Now, with a hydrohalide format and controlled cyano and phenyl placement, we see fewer issues logged on customer feedback forms. In recent contract projects, this material held up under long-haul shipment for export markets, with little loss during repackaging—a win both for inventory managers and synthetic chemists downstream.

    Lab-scale researchers sometimes face unexpected hurdles translating synthetic routes to larger reactors. On multiple occasions, we have been contacted directly by process engineers stumped by crystallization behavior only to realize the culprit stemmed from overlooked salt forms or fines content. With hands-on manufacturing experience, we now adjust the drying step timing and screen out fines that could mess with downstream slurry handling. In ongoing production, blending old lessons with feedback from formulation chemists on the ground means we avoid the pitfalls of generic, uncalibrated supplier material.

    Specifications that Matter in Day-to-Day Operations

    Practitioners gravitate to material that doesn’t slow down their day. Our hydrochloride salt shows consistent powder flow in weighing rooms, with caking and static issues reduced by precise milling and screening. The water content, measured by Karl Fischer titration every batch, typically stays below 0.3 percent—an outcome that allows manuals and reaction protocols to specify quantities without long recalculations for variable loss on drying. This makes planning easier for project leads under pressure to minimize downtime between API steps.

    Packing lines are another flashpoint for reliability. Early on, transport complaints led us to double-layer every polybag and dehumidify storage, a step taken after seeing condensation trouble in congested transit hubs. Every technical manager here can recount at least one instance where an aside by a customer, often just a single unexplained crystalline crust, explained product loss in transit. It’s easy to underestimate how much these practical details trim costs and keep timelines ironclad.

    Why 1-Benzyl-4-Cyano-4-Phenylpiperidine Hydrochloride Stands Apart from Analogues

    Rival piperidine derivatives, whether bearing simpler alkyl or other aromatic substitutions, do not match this compound in terms of process-longevity during multistep reaction runs. Some alternatives, while less expensive on paper, falter because their physical forms don’t keep to specification over time. The hydrochloride version prevents baseline drift in analysis and resists hydrolysis better than base forms, a fact noticed by those who tackle long syntheses with many purification steps.

    Colleagues in both analytical and formulation arms report that side reactions are less of a concern when starting from this stable hydrochloride—less time devoted to scavenging unwanted benzylic by-products or chasing down low-level errors in subsequent steps. This translates to better batch-to-batch consistency for teams scaling up or working on tech transfer. For process engineers who once spent days chasing anomalies in solid-liquid separation during workup, it’s been a relief to use material with better-defined crystal habits.

    Shared Lessons from Direct Handling and Customer Feedback

    Few variables expose themselves as quickly in batch production as those related to solubility and compatibility with other solvents. Handling this piperidine hydrochloride in real reaction vessels, not just in theory or lab-scale demonstrations, reveals its real edge. Scale-up teams have emphasized that precipitation and dissolution steps run smoother thanks to a powder-fine control in our particle sizing. Any tendency for clumping or unpredictable settling means trouble for throughput in continuous or batch modes. Every time a complaint hits the plant, we take it as a lesson in fixing not just what went wrong, but how people use the compound in real workspaces.

    Documentation matters. We supply full analytical dossiers with chromatograms and spectra to chemists under NDAs who want to replicate results and avoid guesswork during regulatory audits. Recent trends show increased scrutiny from partners in regulated markets; our internal teams now spend as much time on cross-checking data sets as they do mixing or drying. That’s not a luxury, but a reflection of how often accuracy means the difference between a delayed launch and a smooth process filing.

    Potential Challenges and Solutions Shaped by Industry Experience

    Scaling up always exposes hidden variables. Early trials at the pilot stage taught us that when working with high-activity piperidine derivatives like this, trace water content can sabotage entire crystal crops and skew subsequent yields in catalysis steps. We tackled this with staged drying in controlled-humidity environments—a process improvement suggested by team leads frustrated by sticky, half-dried powders from outsourced suppliers.

    Solvent compatibility was another recurring theme in route optimization attempts. In projects where direct substitution with cheaper piperidines tempted process teams, the reality was more time lost to purification and rework. Relying on hydrochloride not only stabilizes the product, it supports solvent exchange steps, allowing for easier integration with both protic and aprotic media. Colleagues on the plant floor have migrated several processes over to this route after chasing down the headaches of methyl or ethyl analogues that left behind hard-to-remove traces and needed extra rechecks on analytical cleanup.

    We have avoided the problems associated with fine powder loss in transfer by investing in process-scale dust collection and establishing clear procedures for staged emptying of bags and drums. Facilities managers and EH&S auditors both pushed for more attention here, remembering past incidents with uncontrolled dust that complicated both housekeeping and compliance.

    What Makes Consistency Non-Negotiable for Our Operation

    Every attempt to cut corners—either by adjusting supplier spec tolerances or combining batches that fell just short of target—has ended up creating more rework and lost time along the value chain. In the world of specialty chemicals, few things matter more than trust between operator, supervisor, and customer. Our policy is simple: every batch matching spec, or it does not leave the gate. Lab techs here have seen firsthand how even minor shifts in particle size or contaminant profile create headaches for reactors and centrifuges downstream.

    The chorus from experienced foremen matches what purchasing teams want to hear: steady particle size distribution, no “mystery lumps”, and no unexplained loss in bulk weight over time. Scaling up those lessons hasn’t required heroics—just paying attention to things like residence time in dryers, warehousing temperature, and humidity control. Colleagues in regions dealing with monsoon or freeze-thaw cycles have highlighted how reliable hydrochloride batches keep process lines on schedule without panicked re-extraction or sudden recapitalizing on storage improvements.

    Supporting Regulatory and Environmental Goals from the Start

    Stringent oversight in regulated markets isn’t just red tape. It’s daily reality for anyone producing compounds targeting downstream sensitive pharmaceutical processes. Our formulation teams learned that just cutting a step here or there never works; every part of the batch record stands up to audit, and full traceability for all synthetic steps gets built into the process files at every campaign. Environmental targets mean adopting green solvents where possible and running recirculation or recovery on rinse solutions—lessons picked up long before the most recent batch of compliance deadlines hit the news cycle.

    Our plant follows integrated management systems, blending ISO-driven documentation with ground-level tweaks that arise from recurring feedback. Teams flag any spikes in waste generation or solvent loss, and every quarter, operations and compliance staff review findings for leaner, cleaner methods. The compound fits comfortably into these systems, thanks mostly to the consistent hydrochloride salt format, which shortens workup and allows for simplified washing and waste reduction.

    Keeping Production Scalable Without Sacrificing Quality

    Many facilities can deliver a handful of kilos, but ramping to ton-scale, year after year, has forced us to work hard on ensuring every kilo looks and behaves the same. Lessons from expansion include constant upgrades to reactor monitoring, blending isolation and automation with a hands-on approach at the filter and drying stages. Cross-training between senior technicians and junior process chemists ensures institutional knowledge on polymorphs, particle sizing, and handling does not fade as teams evolve.

    Routine audits by customers’ technical teams keep us focused on actual usage scenarios. Time spent on blending in additives, adjusting pH, or tracking residual solvents used to cost us in both reputation and cost-overruns. Experience has pushed us toward continuous review and process tuning so that spec drift—if it ever appears—gets traced and corrected before anything ends up in a customer’s reactor.

    Facing the Future: Evolving Demands and Supplying Confidence

    Over the years, project managers and lead process chemists have shared where shipment delays or unexpected spec shifts shut down pilot lines or forced rescheduling of clinical runs. Stability in both product and documentation gets baked into every drum, supported by a tight-knit loop between R&D, QC, and logistics. The market has shifted toward higher scrutiny on every incoming raw material, and batch-to-batch traceability now supports not only regulatory compliance but the operational certainty needed to handle tight project timelines.

    For those building out new synthetic programs or troubleshooting persistent process issues due to variable intermediate quality, the story behind the compound matters as much as the numbers on the cert. Direct manufacturing experience—real lessons pulled from the noise and setbacks of live production—teaches that the difference between a seamless run and a stalled campaign hinges on details tracked, measured, and checked at every point.

    Looking Back, Forging Ahead: Practical Solutions for Modern Synthesis

    No supplier can promise the moon, but those with a manufacturing background know which promises count. Confident, repeatable outcomes come only from careful, documented, and consistently improved methods. For every process chemist, logistics manager, or QC supervisor fielding the consequences of inconsistency, there’s solace—and competitive advantage—in relying on material crafted to real-world specifications and tested under working conditions.

    By keeping the entire lifecycle, from point of synthesis to packed batch, under a single roof with relevant controls at each stage, the transition from kilogram to metric ton no longer carries surprises. Our investment in batch tracking, hands-on process control, and open feedback with customer teams stands at the heart of our offering, supporting outcomes that do not just meet, but stand up in practice to the real pressures of the chemical industry.